163 related articles for article (PubMed ID: 35474282)
1. [Seroconversion of anti-aquaporin-4 antibody in a patient with neuromyelitis optica spectrum disorder: a case report].
Shimoyama K; Akahori M; Ishio Y; Yanagihara C
Rinsho Shinkeigaku; 2022 May; 62(5):351-356. PubMed ID: 35474282
[TBL] [Abstract][Full Text] [Related]
2. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
[TBL] [Abstract][Full Text] [Related]
3. [A case of neuromyelitis optica spectrum disorders associated with primary biliary cholangitis: a twelve year follow-up study].
Sakai T; Kondo M; Kawana Y; Inoue R
Rinsho Shinkeigaku; 2022 Mar; 62(3):190-197. PubMed ID: 35228461
[TBL] [Abstract][Full Text] [Related]
4. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.
Camera V; Holm-Mercer L; Ali AAH; Messina S; Horvat T; Kuker W; Leite MI; Palace J
JAMA Netw Open; 2021 Dec; 4(12):e2137833. PubMed ID: 34878547
[TBL] [Abstract][Full Text] [Related]
5. ABCB1 gene polymorphisms impact the effect of high-dose intravenous methylprednisolone therapy on optic neuritis associated with AQP4-IgG-positive neuromyelitis optica spectrum disorder.
Dai Y; Ni S; Wu F; Guo S; Zhao X; Wang J
J Clin Pharm Ther; 2022 Sep; 47(9):1379-1387. PubMed ID: 35488449
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C
Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction Models.
Wang L; Du L; Li Q; Li F; Wang B; Zhao Y; Meng Q; Li W; Pan J; Xia J; Wu S; Yang J; Li H; Ma J; ZhangBao J; Huang W; Chang X; Tan H; Yu J; Zhou L; Lu C; Wang M; Dong Q; Lu J; Zhao C; Quan C
Front Immunol; 2022; 13():873576. PubMed ID: 35432315
[TBL] [Abstract][Full Text] [Related]
8. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
[TBL] [Abstract][Full Text] [Related]
9. Radiologically isolated aquaporin-4 antibody neuromyelitis optica spectrum disorder.
Abdel-Mannan O; Klein A; Bachar Zipori A; Ben-Sira L; Fattal-Valevski A; Hacohen Y; Meirson H
Mult Scler; 2022 Apr; 28(4):676-679. PubMed ID: 35332817
[TBL] [Abstract][Full Text] [Related]
10. Recurrent optic neuritis in a patient with Sjogren syndrome and neuromyelitis optica spectrum disorder: A case report.
Zheng W; Liu X; Hou X; Zhu Y; Zhang T; Liao L
Medicine (Baltimore); 2020 Nov; 99(45):e23029. PubMed ID: 33157952
[TBL] [Abstract][Full Text] [Related]
11. Aquaporin-4-antibody-positive Neuromyelitis Optica Spectrum Disorder in a Patient with Charcot-Marie-Tooth Disease Type 1A.
Hamada Y; Takahashi K; Kanbayashi T; Hatanaka Y; Kobayashi S; Sonoo M
Intern Med; 2021 May; 60(10):1611-1614. PubMed ID: 33361678
[TBL] [Abstract][Full Text] [Related]
12. Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease.
Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
Mult Scler Relat Disord; 2021 Nov; 56():103222. PubMed ID: 34461572
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Severe rebound after withdrawal of fingolimod in a patient with neuromyelitis optica spectrum disorder.
Lin W; Chou CH; Yang FC; Tsai CK; Lin YK; Sung YF
Front Immunol; 2023; 14():1115120. PubMed ID: 37122715
[TBL] [Abstract][Full Text] [Related]
14. Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study.
Kessler RA; Mealy MA; Jimenez-Arango JA; Quan C; Paul F; López R; Hopkins S; Levy M
Mult Scler Relat Disord; 2017 Oct; 17():198-201. PubMed ID: 29055457
[TBL] [Abstract][Full Text] [Related]
15. Sick sinus syndrome as the initial manifestation of neuromyelitis optica spectrum disorder: a case report.
Hamaguchi M; Fujita H; Suzuki T; Suzuki K
BMC Neurol; 2022 Feb; 22(1):56. PubMed ID: 35164681
[TBL] [Abstract][Full Text] [Related]
16. Mirror-Image Lesions in Sequential Relapses of AQP4-Positive Neuromyelitis Optica Spectrum Disorder.
Muir RT; Bharatha A; Rotstein D
Front Neurol; 2020; 11():414. PubMed ID: 32477258
[TBL] [Abstract][Full Text] [Related]
17. Intractable nausea and vomiting as an uncommon presentation in an anti-aquaporin 4-positive patient.
Wang L; Su HJ; Qi JL; E RF; Zhao K
J Int Med Res; 2018 Aug; 46(8):3411-3416. PubMed ID: 29806512
[TBL] [Abstract][Full Text] [Related]
18. The relationship between aquaporin-4 antibody status and visual tract integrity in neuromyelitis optica spectrum disorders: A visual evoked potential study.
Barć K; Gospodarczyk-Szot K; Nojszewska M; Podlecka-Piętowska A; Zakrzewska-Pniewska B
Mult Scler Relat Disord; 2020 Sep; 44():102265. PubMed ID: 32575026
[TBL] [Abstract][Full Text] [Related]
19. Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.
Nishimura H; Enokida H; Sakamoto T; Takahashi T; Hayami H; Nakagawa M
J Artif Organs; 2018 Sep; 21(3):378-382. PubMed ID: 29675599
[TBL] [Abstract][Full Text] [Related]
20. Sequential Optic Neuritis: A Neuromyelitis Optica Spectrum Disorder.
Alam M; Haq MAU; Iqbal A; Ullah K; Nabi D
J Coll Physicians Surg Pak; 2019 Apr; 29(4):379-380. PubMed ID: 30925966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
